News and History
-
Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight Loss
Read More: Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight LossOn Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…
-
U.S. CDC chief exits after weeks in role, three top officials resign
Read More: U.S. CDC chief exits after weeks in role, three top officials resignOn Aug. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monarez has left…
-
Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
Read More: Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…
-
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64
Read More: Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64On Aug. 27, 2025, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) has approved the…
-
Mexico reports 53% increase in flesh-eating screwworm cases since July
Read More: Mexico reports 53% increase in flesh-eating screwworm cases since JulyOn Aug. 27, 2025, Mexico has recorded 5,086 cases of flesh-eating screwworm in animals as of August 17,…
-
Microsoft co-founder Paul Allen’s final act: New $3.1B foundation bets big on science and tech
Read More: Microsoft co-founder Paul Allen’s final act: New $3.1B foundation bets big on science and techOn Aug. 27, 2025, a new fun created by Allen’s estate under the late Microsoft co-founder’s instructions, was…
-
Aedes aegypti non-native mosquito detected in Oregon
Read More: Aedes aegypti non-native mosquito detected in OregonOn Aug. 26, 2025, health officials in Ashland, Oregon reported that six Aedes aegypti mosquitoes were found in…
-
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
Read More: Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal PreparednessOn Aug. 26, 2025, Osivax announced it has secured $19.5 million in funding from the Biomedical Advanced Research…
-
Valneva shares tumble after suspension of U.S. chikungunya vaccine license
Read More: Valneva shares tumble after suspension of U.S. chikungunya vaccine license -
AbbVie to Acquire Gilgamesh Pharma’s Investigational Therapy for Major Depressive Disorder for $1.2 Billion
Read More: AbbVie to Acquire Gilgamesh Pharma’s Investigational Therapy for Major Depressive Disorder for $1.2 BillionOn Aug. 25, 2025, AbbVie and Gilgamesh Pharmaceuticals announced a definitive agreement under which AbbVie will acquire Gilgamesh’s…
-
In a first, pig lung survives and functions—briefly—in a person
Read More: In a first, pig lung survives and functions—briefly—in a personOn Aug. 25, 2025, in a small step forward for the long-struggling field of xenotransplantation, surgeons in China…
-
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
Read More: Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North CarolinaOn Aug. 25, 2025, Genentech, a member of the Roche Group broke ground on its newest U.S. manufacturing site…
-
Tuskegee University breaks ground on $14 Million game-changing genomic research center
Read More: Tuskegee University breaks ground on $14 Million game-changing genomic research centerOn Aug. 25, 2025, Tuskegee University cancer researchers gathered under two green tents to celebrate a day they…
-
MannKind to Acquire scPharmaceuticals for $360 million
Read More: MannKind to Acquire scPharmaceuticals for $360 millionOn Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
-
U.S. confirms nation’s first travel-associated human screwworm case connected to Central American outbreak
Read More: U.S. confirms nation’s first travel-associated human screwworm case connected to Central American outbreakOn Aug. 24, 2025, the U.S. Department of Health and Human Services reported the first human case in…
-
Award-winning HIV scientist Shan Liang leaves U.S. to join Chinese research institute
Read More: Award-winning HIV scientist Shan Liang leaves U.S. to join Chinese research instituteOn Aug. 23, 2025, award-winning HIV scientist Shan Liang, a tenured associate professor at the Washington University School…
-
MSDH Declares Public Health Emergency on Infant Mortality
Read More: MSDH Declares Public Health Emergency on Infant MortalityOn Aug. 21, 2025, the Mississippi State Department of Health (MSDH) declared a public health emergency in response…
-
Eliminating tobacco use could reduce age-related macular degeneration
Read More: Eliminating tobacco use could reduce age-related macular degenerationOn Aug. 21, 2025, the Institute for Health Metrics and Evaluation (IHME) announced a recent study aimed to…
-
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Read More: Kite to Acquire Interius BioTherapeutics to Advance In Vivo PlatformOn Aug. 21, 2025, Kite, a Gilead Company company, announced that it has entered into a definitive agreement…
-
Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina Facility
Read More: Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina FacilityOn Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…
